Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $740 - $1,203
30 New
30 $0
Q1 2020

Aug 30, 2024

SELL
$32.37 - $59.36 $155,052 - $284,334
-4,790 Closed
0 $0
Q4 2019

Aug 30, 2024

SELL
$32.22 - $50.07 $11,695 - $18,175
-363 Reduced 7.04%
4,790 $230 Million
Q3 2019

Aug 30, 2024

SELL
$33.82 - $48.17 $12,479 - $17,774
-369 Reduced 6.68%
5,153 $174 Million
Q2 2019

Aug 30, 2024

BUY
$35.42 - $45.0 $194,526 - $247,140
5,492 Added 18306.67%
5,522 $248 Million
Q2 2018

Aug 30, 2024

SELL
$25.7 - $47.88 $402,667 - $750,183
-15,668 Closed
0 $0
Q1 2018

Aug 30, 2024

SELL
$17.46 - $32.59 $51,576 - $96,270
-2,954 Reduced 15.86%
15,668 $423 Million
Q3 2017

Aug 30, 2024

BUY
$16.81 - $21.61 $121,956 - $156,780
7,255 Added 63.83%
18,622 $373 Million
Q2 2017

Aug 30, 2024

BUY
N/A
11,337
11,367 $208 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.